No article text was recorded for this version.
mucosal immunity gap
Version 1 of 135 papers58 conceptsfrozen 2026-10-04
Papers in this version
- Blog: Intranasal inoculation of an MVA-based vaccine induces IgA and protects the respiratory tract of hACE2 mice from SARS-CoV-2 infection
- Blog: The technologies and their applications in the prevention and control of main porcine viral diarrhea
- Blog: A Novel Bacterium-Like Particle Vaccine Displaying the MERS-CoV Receptor-Binding Domain Induces Specific Mucosal and Systemic Immune Responses in Mice
- Blog: Development of universal influenza vaccines: strategies for broadly cross-reactive influenza vaccine responses
- Blog: Intrinsic 4-1BB signals are indispensable for the establishment of an influenza-specific tissue-resident memory CD8 T-cell population in the lung
- Blog: Protective efficacy of intranasal inactivated pseudorabies vaccine is improved by combination adjuvant in mice
- Blog: Nanotechnology-driven advances in intranasal vaccine delivery systems against infectious diseases
- Blog: Meta-analysis of HIV-1 vaccine elicited mucosal antibodies in humans
- Blog: Evolving SARS-CoV-2 Vaccines: From Current Solutions to Broad-Spectrum Protection
- Blog: An Overview of Tissue-Resident Memory T Cells in the Intestine: From Physiological Functions to Pathological Mechanisms
- Blog: Advanced Vaccine Design Strategies against SARS-CoV-2 and Emerging Variants
- Blog: Bacteriophage T4 Vaccine Platform for Next-Generation Influenza Vaccine Development
- Blog: Magnitude and breadth of antibody cross-reactivity induced by recombinant influenza hemagglutinin trimer vaccine is enhanced by combination adjuvants
- Blog: Роль российских ученых в разработке сибиреязвенных вакцин
- Blog: Expression of Toll-like receptor 4 in lungs of immune-suppressed rat with Acinetobacter baumannii infection
- Blog: One or two injections of MVA-vectored vaccine shields hACE2 transgenic mice from SARS-CoV-2 upper and lower respiratory tract infection
- Blog: Oral Cytological Findings in Mobility Service Dogs
- Blog: Exploring the standardized detection and sampling methods of human nasal SARS-CoV-2 RBD IgA
- Blog: O01.6 Persistent SIV-Seronegative Macaque Monkeys Generate Multi-Cytokine Anti- SIV Mucosal Immune Responses Following Serial Low-Dose SIV Mucosal Challenge
- Blog: Generation of whole tumor cell vaccine for on-demand manipulation of immune responses against cancer under near-infrared laser irradiation
- Blog: Targeting SARS-CoV-2 receptor-binding domain to cells expressing CD40 improves protection to infection in convalescent macaques
- Blog: Exploring the standardization of human nasal antibody measurements
- Blog: Inhalable SARS-CoV-2 vaccine for single-dose dry powder aerosol immunization
- Blog: Development of a reverse genetics system for respiratory syncytial virus long strain and an immunogenicity study of the recombinant virus
- Blog: Chrysanthemum sporopollenin: A novel vaccine delivery system for nasal mucosal immunity
- Blog: Computational Design and Glycoengineering of Interferon‐Lambda for Nasal Prophylaxis Against Respiratory Viruses
- Blog: The Role of Salivary IgA Antibody against Periodontopathic Bacteria.
- Blog: Transcriptome Profiling Reveals Th17-Like Immune Responses Induced in Zebrafish Bath-Vaccinated with a Live Attenuated Vibrio anguillarum
- Blog: Development of Different Methods for Preparing Acinetobacter baumannii Outer Membrane Vesicles Vaccine: Impact of Preparation Method on Protective Efficacy
- Blog: Protective immunity against Trichinella spiralis infection induced by TsNd vaccine in mice
- Blog: Intranasal mask for protecting the respiratory tract against viral aerosols
- Blog: P19-57 LB. Gene-based vaccination protects against mucosal infection by a heterologous highly pathogenic SIV isolate in rhesus monkeys
- Blog: Discrete populations of isotype-switched memory B lymphocytes are maintained in murine spleen and bone marrow
- Blog: Early lymph node T follicular helper cell signalling hub drives influenza vaccine response in an ancestrally diverse cohort
- Blog: Protocol of a randomised controlled trial characterising the immune responses induced by varicella-zoster virus (VZV) vaccination in healthy Kenyan women: setting the stage for a potential VZV-based HIV vaccine
History & citation
Current · Permanent link
- Mucosal Vaccines for Sterilizing Immunity against Respiratory Pathogens merged into this direction (60% overlap)
- Establishing Localized Immune Garrisons via Mucosal Vaccine Delivery merged into this direction (67% overlap)
Cite this direction
Latest version (a living page):
@misc{lacuna_mucosal_immunity_gap_8f4046e2,
title = {mucosal immunity gap},
author = {{Lacuna}},
howpublished = {Lacuna research direction},
year = {2026},
url = {https://lacuna.tiptreesystems.com/direction/mucosal-immunity-gap/rdr_8f4046e22dec45a9913ed1bfa0b0e35d},
note = {Latest version of a living research direction; cite a version for a fixed text. Accessed 2026-11-20},
}This exact version (version 1, frozen text):
@misc{lacuna_mucosal_immunity_gap_8f4046e2_v1,
title = {mucosal immunity gap},
author = {{Lacuna}},
howpublished = {Lacuna research direction},
year = {2026},
url = {https://lacuna.tiptreesystems.com/direction/mucosal-immunity-gap/rdr_8f4046e22dec45a9913ed1bfa0b0e35d/v/1},
note = {Version 1, frozen 2026-10-04. Accessed 2026-11-20},
}